Larry Gold is CEO, SomaLogic, 1745
38th Street, Boulder, CO 80301
lgold@somalogic.com.
Reporter ribozymes that allow monitoring of protein−nucleic
acid and protein−protein interactions facilitate rapid identification of
inhibitors for use in drug discovery.
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated
